Product image of Minkian (Drospirenone, Ethinylestradiol | Lactose) supplied by GNH India

Minkian

Active Ingredient:
Drospirenone, Ethinylestradiol | Lactose
Origin:
EU

Minkian (Drospirenone, Ethinylestradiol | Lactose)

Drospirenone/Ethinylestradiol, the active ingredient in Minkian, is a combined oral contraceptive presented as a tablet for oral use. It prevents pregnancy and helps regulate menstrual cycles in women of reproductive age.

GNH India supplies Minkian as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Gedeon Richter Plc.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Minkian, a combined oral contraceptive, is used to manage reproductive‑health conditions.

  • Contraception: Provides reliable prevention of pregnancy when taken as directed.
  • Menstrual cycle regulation: Helps achieve more predictable bleeding patterns and reduces dysmenorrhea.
  • Acne improvement: May reduce moderate acne associated with hormonal fluctuations.

How It Works

  • Drospirenone/Ethinylestradiol works by suppressing the hypothalamic‑pituitary‑ovarian axis, lowering luteinizing hormone (LH) and follicle‑stimulating hormone (FSH) secretion, which prevents ovulation. The progestogenic component also thickens cervical mucus and induces endometrial changes that hinder implantation, while the estrogen component stabilises the endometrium and supports cycle control.

Side Effects

Minkian may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

  • Nausea or vomiting
  • Headache or migraine
  • Breast tenderness
  • Weight gain or fluid retention
  • Mood changes or irritability
  • Spotting or breakthrough bleeding

Serious or Rare Side Effects

  • Deep‑vein thrombosis or pulmonary embolism
  • Stroke or myocardial infarction
  • Severe hypertension
  • Liver dysfunction or jaundice
  • Allergic reactions such as rash, angioedema, or anaphylaxis

Precautions & Warnings

Before prescribing Minkian, clinicians should consider several safety factors.

  • Contraindications: Do not use in women with known thromboembolic disorders, active liver disease, or hormone‑sensitive cancers.
  • Smoking: Avoid in women over 35 who smoke, due to increased cardiovascular risk.
  • Medication review: Assess concurrent use of enzyme‑inducing drugs that may reduce efficacy.
  • Pregnancy: Discontinue if pregnancy is confirmed; discuss alternative contraception.
  • Store at ambient temperature: Keep below 25 °C, retain in original packaging, and protect from moisture.

Avoid Interactions

Minkian can interact with several drug classes, altering its effectiveness or safety profile.

Major Interactions (Avoid)

  • Strong CYP3A4 inducers (e.g., rifampin, carbamazepine, phenytoin): may markedly reduce contraceptive efficacy.
  • Certain antiretrovirals (e.g., efavirenz): can lower hormone levels, increasing pregnancy risk.

Moderate Interactions (Monitor Closely)

  • Antifungal agents (e.g., ketoconazole, itraconazole): may increase hormone concentrations, raising side‑effect potential.
  • St. John’s wort: may modestly decrease effectiveness; advise additional non‑hormonal contraception.
  • Diuretics or antihypertensives: monitor blood pressure as hormonal changes can affect fluid balance.

Frequently Asked Questions

Minkian is a combined oral contraceptive containing drospirenone and ethinylestradiol. It is prescribed to prevent pregnancy, regulate menstrual cycles, and may also be used to treat moderate acne in women of reproductive age.

The combination suppresses the hypothalamic‑pituitary‑ovarian axis, reducing LH and FSH release, which blocks ovulation. Drospirenone also thickens cervical mucus and alters the endometrium, while ethinylestradiol stabilises the uterine lining, together preventing fertilisation and implantation.

The dosing regimen for Minkian is determined by the prescribing clinician. Typically, it is taken as a daily oral tablet following the specific cycle schedule indicated on the prescription label.

Minkian is contraindicated during pregnancy; it should be stopped if pregnancy is confirmed. Limited data exist for breastfeeding, and the benefits and risks should be evaluated by a healthcare professional before use.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Minkian contains drospirenone, a progestin with anti‑androgenic and mild diuretic properties, which may offer advantages in reducing water retention and acne compared with some older progestins. Efficacy in preventing pregnancy is comparable to other approved combined oral contraceptives.

Minkian tablets should be stored at ambient temperature, below 25 °C, in the original blister pack. Keep them away from moisture, heat and direct sunlight to maintain potency.

Minkian is taken orally, once daily, at the same time each day. The typical regimen involves 21 active tablets followed by a 7‑day hormone‑free interval, during which withdrawal bleeding occurs.

Serious risks include venous thromboembolism, arterial thrombosis (stroke or myocardial infarction), severe hypertension, and liver disorders. Women with a history of clotting disorders, smoking over age 35, or certain cardiovascular conditions should avoid use.

Minkian is contraindicated in women with known or suspected pregnancy, active or history of thromboembolic disease, uncontrolled hypertension, certain cancers (e.g., breast, liver), severe liver disease, or those who are allergic to any component of the tablet.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Drospirenone, Ethinylestradiol | Lactose

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT